Correlation Between BioNTech and Moderna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioNTech and Moderna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Moderna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and Moderna, you can compare the effects of market volatilities on BioNTech and Moderna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Moderna. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Moderna.

Diversification Opportunities for BioNTech and Moderna

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between BioNTech and Moderna is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Moderna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moderna and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Moderna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moderna has no effect on the direction of BioNTech i.e., BioNTech and Moderna go up and down completely randomly.

Pair Corralation between BioNTech and Moderna

Assuming the 90 days trading horizon BioNTech SE is expected to generate 1.18 times more return on investment than Moderna. However, BioNTech is 1.18 times more volatile than Moderna. It trades about 0.16 of its potential returns per unit of risk. Moderna is currently generating about -0.23 per unit of risk. If you would invest  7,865  in BioNTech SE on August 30, 2024 and sell it today you would earn a total of  3,515  from holding BioNTech SE or generate 44.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

BioNTech SE  vs.  Moderna

 Performance 
       Timeline  
BioNTech SE 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BioNTech reported solid returns over the last few months and may actually be approaching a breakup point.
Moderna 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moderna has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

BioNTech and Moderna Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioNTech and Moderna

The main advantage of trading using opposite BioNTech and Moderna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Moderna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moderna will offset losses from the drop in Moderna's long position.
The idea behind BioNTech SE and Moderna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies